FRANCISMD, RUSSELLRG, FLEISCHH. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Sciences1969; 165: 1264-6.
2.
AVIOLILV. Bone diseases. In: WyngaardenJB, SmithLH eds. Cecil's textbook of medicine.16th ed.Philadelphia: WB Saunders, 1982: 1318-53.
MAUTALENC, GONZALEZD, BLUMENFELDEL, ARAUJOES, SCHAJOWICZF. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP). Clin Orthop1986; 207: 150-5.
5.
GIBBSCJ, AARONJE, PEACOCKM. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate. Br Med J1986; 292: 1227-9.
6.
BOYCEBF, FOGELMANI, RALSTONS, SMITHL, JOHNSTONE, BOYLEIT. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. Lancet1984; 1: 821-4.
7.
JOHNSTONCC, ALTMANRD, CANFIELDRE, FINERMANGAM, TAULBEEJD, EBERTML. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). Clin Orthop1983; 172: 186-94.
8.
FINERMANGAM, STOVERSL. Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP. Metab Bone Dis Relat Res1981; 4&5: 337-42.
9.
WHARTONGW, MORGANTH. Ankylosis in the paralyzed patient. J Bone Joint Surg1970; 52A: 105-12.
10.
HARDYAG, DICKSONJW. Pathological ossification in traumatic paraplegia. J Bone Joint Surg1963; 45B: 76-87.
11.
SPIELMANG, GENNARELLIJA, ROGERSCR. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil1983; 64: 539-42.
12.
GARLANDDE, BLUMCE, WATERSRL. Periarticular heterotopic ossification in head-injured adults. J Bone Joint Surg1980; 62A: 1143-6.
13.
BAYLEYSJ. Funnybones: review of problem of heterotopic bone formation. Orthop Review1979; 8: 113-20.
14.
GARLANDDE, ALDAYB, VENOSKG, VOGTJC. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. Clin Orthop1983; 176: 97-200.
